PA5-80529
antibody from Invitrogen Antibodies
Targeting: CXCL2
CINC-2a, GRO2, GROb, MGSA-b, MIP-2a, SCYB2
Antibody data
- Antibody Data
- Antigen structure
- References [0]
- Comments [0]
- Validations
- Western blot [3]
Submit
Validation data
Reference
Comment
Report error
- Product number
- PA5-80529 - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- CXCL2 Polyclonal Antibody
- Antibody type
- Polyclonal
- Antigen
- Recombinant full-length protein
- Description
- This product is preservative free. It is recommended to add sodium azide to avoid contamination (final concentration 0.05%-0.1%). This antibody has specificity for Human CXCL2/MIP-2.
- Reactivity
- Human
- Host
- Rabbit
- Isotype
- IgG
- Vial size
- 100 µL
- Concentration
- 1 mg/mL
- Storage
- Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
No comments: Submit comment
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Western blot analysis of CXCL2 in Lane A: Daudi Whole Cell Lysate (30 µg). Samples were probed using a CXCL2 Polyclonal Antibody (Product # PA5-80529) at a 1:500 dilution, followed by a Goat Anti-Rabbit IgG (H+L), Dylight 800 Secondary Antibody at a 1:10000 dilution. Western blot was performed under reducing conditions. Predicted band size:11 kDa. Observed band size:11 kDa.
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Western Blot using CXCL2 Polyclonal Antibody (Product # PA5-80529) at 1:500 dilution. Lane A: Daudi Whole Cell Lysate. Lysates/proteins at 30 μg per lane. Secondary Goat Anti-Rabbit IgG H&L (DyLight™ 800) at 1:10,000 dilution. Developed using the Odyssey technique. Performed under reducing conditions. Predicted band size: 11 kDa. Observed band size: 11 kDa.
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Western blot was performed using Anti-CXCL2 Polyclonal Antibody (Product # PA5-80529) and a 7.9 kDa band corresponding to C-X-C motif chemokine 2 was observed LPS treated and secretion blocked HUVEC cells. Whole cell extracts (40 µg lysate) of HUVEC (Lane 1), PTI treated HUVEC (Lane 2), LPS treated HUVEC (Lane 3), LPS and PTI treated HUVEC (Lane 4) were electrophoresed using Novex™ 16% Tricine Protein Gel (Product # EC6695BOX). Resolved proteins were then transferred onto a PVDF membrane (Product # LC2002) by iBlot® 2 Dry Blotting System (Product # IB21001). The blot was probed with the primary antibody (1:1000 dilution) and detected by chemiluminescence with Goat anti-Rabbit IgG (H+L) Superclonal™ Recombinant Secondary Antibody, HRP (Product # A27036, 1:10000 dilution) using the iBright FL 1000 (Product # A32752). Chemiluminescent detection was performed using Novex® ECL Chemiluminescent Substrate Reagent Kit (Product # WP20005). Uncharacterised bands (*) at ~36 kDa and ~90 kDa was also detected across the panel.